Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-142-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2011-02-16"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20110216.11.3-142-000"2
lpv:hasSubsequent	lp_eu:2011-02-16-Speech-3-143-0002
lpv:speaker	lp:Anna Záborská2
lpv:spokenAs	substitute; ENVI (2009-07-16--2012-01-18)3 member; Delegation for relations with Canada (2009-09-16--2014-06-30)3 substitute; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-16--2014-06-30)3 member; FEMM (2009-07-16--2012-01-18)3 member; DEVE (2009-07-16--2012-01-18)3 member_of_the_bureau; EPP (2009-09-16--2014-06-30)3 unknown; Kresťanskodemokratické hnutie (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the Pan-African Parliament (2009-09-16--2014-06-30)3
lpv:translated text	"Mr President, we have been obliged to adopt a report today on the protection of patients from falsified medicines, partly because the market liberalism advocated by the European Commission has opened the door to the market in falsified products. Deregulated competition leads to medicines being falsified for the benefit of companies. The victims are consumers. I voted for this report even though I am not entirely convinced that the definition of a falsified product is correct. Furthermore, it is not entirely clear who should be punished when a falsified medicine is found. However, it is an initial step in the right direction, and we shall see in a year’s time if our action was effective."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph